Takehana Yasuo | Central Research Laboratory Kissei Pharmaceutical Co. Ltd.

スポンサーリンク

概要

• Takehana Yasuoの詳細を見る
• 同名の論文著者
• Central Research Laboratory Kissei Pharmaceutical Co. Ltd.の論文著者

関連著者

• Takehana Yasuo

  Central Research Laboratory Kissei Pharmaceutical Co. Ltd.

• Hamano Shuichiro

  Central Research Laboratories Kissei Pharmaceutical Co. Ltd.

• KOMATSU Hidetada

  Central Research Laboratories, Kissei Pharmaceutical Co., Ltd.

• KOMATSU Hidetada

  Central Research Laboratories, Kissei Pharmaceutical Cc., Ltd.

• Kikuchi Shinji

  Central Research Laboratory Kissei Pharmaceutical Company Ltd.

• HAMANO Shuichiro

  Central Research Laboratories, Kissei Pharmaceutical Co., Ltd.

• Ujiie Arao

  Central Research Laboratories Kissei Pharmaceutical Co. Ltd.

• Momose Den-ichi

  Central Research Laboratory Kissei Pharmaceutical Co. Ltd.

• Hiraku Seiji

  Research Institute Ono Pharmaceutical Co. Ltd.

• Kobayashi Toshiro

  Central Research Laboratory Kissei Pharmaceutical Co. Ltd.

• SHINAGAWA Kazuhiko

  Centlar Research Laboratory, Kissei Pharmaceutical Co. Ltd.,

• TSUYUKI Shogo

  Central Research Laboratory, Kissei Pharmaceutical Co. Ltd.,

• TOKUTAKE Yoshiki

  Central Research Laboratory, Kissei Pharmaceutical Co. Ltd.,

• SATO Masaaki

  Central Research Laboratory, Kissei Pharmaceutical Co. Ltd.,

• Shinagawa Kazuhiko

  Centlar Research Laboratory Kissei Pharmaceutical Co. Ltd.

• Tsuyuki Shogo

  Central Research Laboratory Kissei Pharmaceutical Co. Ltd.

• Tokutake Yoshiki

  Central Research Laboratory Kissei Pharmaceutical Co. Ltd.

• Sato Masaaki

  Central Research Laboratory Kissei Pharmaceutical Co. Ltd.

• Okegawa Tadao

  Minase Research Institute, Ono Pharmaceutical Co., Ltd.

• IKEDA Shigeru

  Central Research Laboratories, Kissei Pharmaceutical Cc., Ltd.

もっと見る 閉じる

著作論文

• Pharamcological Characterization of a Novel Long-acting Histamine H_1 Receptor Antagonist, KAA-276
• Beneficial effect of OKY-046, a selective thromboxane A2 synthetase inhibitor, on experimental cerebral vasospasm.
• Inhibitory action of OKY-046HCl, a specific TXA2 synthetase inhibitor, on platelet activating factor(PAF)-induced airway hyperresponsiveness of guinea pigs: Role of TXA2 in development of PAF-induced nonspecific airway hyperresponsiveness.

スポンサーリンク